Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • zatoichi888
    Junior Member
    • May 2013
    • 8

    #1

    How to deal with samples partially without replicates in DESeq?

    I have four groups of samples, 2 groups with replicates and 2 groups without. The data frame is like this:
    expt_design<-data.frame(row.name=colnames(colon)
    + condition=c("GF","SPF","9343","9343","SPT","SPT"))
    Error: unexpected symbol in:
    "expt_design<-data.frame(row.name=colnames(colon)
    condition"
    > expt_design<-data.frame(row.names=colnames(colon),
    + condition=c("GF","SPF","9343","9343","SPT","SPT"))
    > expt_design
    condition
    GF GF
    SPF SPF
    X9343.1 9343
    X9343.2 9343
    SPT.1 SPT
    SPT.2 SPT
    > conditions=expt_design$condition
    > conditions
    [1] GF SPF 9343 9343 SPT SPT
    Levels: 9343 GF SPF SPT

    When I tried to run it gave me this error message:
    >cds=estimateDispersions(cds)
    Error in .local(object, ...) :
    None of your conditions is replicated. Use method='blind' to estimate across conditions, or 'pooled-CR', if you have crossed factors.

    Plz help me to identify the problem and tell me how to deal with partially replicated samples
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Did you read the error message, the fix is contained within it. Also, you should read the DESeq tutorial.

    Comment

    • Simon Anders
      Senior Member
      • Feb 2010
      • 995

      #3
      You might have confused DESeq by passing your "condition" data as a data.frame rather than as a factor. Try again using

      cds <- newCountDataSet( countTable, exptDesign$condition)

      And consider switching to DESeq2. It not only has improved power; we have also improved the interface to avoid problems like this one.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      33 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Working...